
Keywords: پلیمراز; palivizumab; premature infants; disease severity; hospitalizations; AAP; American Academy of Pediatrics; CHD; Congenital heart disease; CLD; Chronic lung disease; ICD-9; International Classification of Diseases, Ninth Revision; O2; Oxygen; PCR; Polymerase